Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating AJM300 in active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AJM300

Snippet

Sponsor: EA Pharma Co., Ltd. | Conditions: Colitis, Ulcerative | Phase 3 | Status: COMPLETED